ERICKA BRUNSON-GILLESPIE: Open Payments
NPI 1184086837 · ANN ARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,001 in 18 payments from 8 companies in 2025. Trend: 2023 $378 · 2024 $1,320 · 2025 $2,001
Food & beverage: $1,004Travel & lodging: $996
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 10 | $1,077 |
| Alnylam Pharmaceuticals Inc. | 2 | $291 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| Amgen Inc. | 1 | $125 |
| Medtronic, Inc. | 1 | $117 |
| ACADIA Pharmaceuticals Inc | 1 | $112 |
| Neurocrine BioSciences, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $33 |
Products named: AMVUTTRA, ULTOMIRIS, EVENITY, SYNCHROMEDII, NUPLAZID, INGREZZA, Auvelity.
Industry payments across MI — which companies pay providers there.
